Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B
Advanced Science · 2025
DOI: 10.1002/advs.202502231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xin-Yan Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cryo-electron Microscopy Center, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Viral Envelope Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kaposi's sarcoma‐associated herpesvirus (KSHV), a member of the human γ‐herpesviruses family, exhibits extensive cellular tropism and is associated with Kaposi's sarcoma and various B‐cell malignancies. Despite its clinical significance, no effective prophylactic vaccines or specific therapeutics are currently available to prevent or treat KSHV infection. Similar to other herpesviruses, KSHV depends on the envelope glycoprotein B (gB) for host receptor recognition and membrane fusion initiation, making gB a prime target for antiviral antibody or vaccine development. In this study, the high‐resolution cryo‐electron microscopy (cryo‐EM) structure of KSHV gB is presented, revealing a unique trimeric conformation resembling the postfusion state observed in other herpesviruses. Additionally, the structure of the non‐neutralizing monoclonal antibody 2C4 bound to KSHV gB domain IV is resolved. The comparative sequence and structure analyses reveal significant homology in neutralizing epitopes between KSHV and Epstein‐Barr virus (EBV) gB, indicating a potential pathway for the development of broad‐spectrum antiviral strategies. These findings provide a foundation for a deeper understanding of KSHV's infectious mechanism and pave the way for the creation of universal interventions against the human γ‐herpesviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cryo-electron Microscopy Center, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.
- Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center…
- Department of Dermatology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
ORCID-Profile: Zheng Liu
Förderung
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- China Postdoctoral Science Foundation
- Program for Guangdong Introducing Innovative and Entrepreneurial Teams
- Guangdong Science and Technology Department
- Key Technologies Research and Development Program
- Shenzhen Science and Technology Innovation Program
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Fang, X. Y., Sun, C., Xie, C., Cheng, B. Z., Lu, Z. Z., Zhao, G. X., Sui, S. F., Zeng, M. S., & Liu, Z. (2025). Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B. Advanced Science. https://doi.org/10.1002/advs.202502231
Vancouver
Fang XY, Sun C, Xie C, Cheng BZ, Lu ZZ, Zhao GX, et al. Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B. Advanced Science. 2025. doi:10.1002/advs.202502231
BibTeX
@article{Fang2025,
author = {Fang, Xin-Yan and Sun, Cong and Xie, Chu and Cheng, Bing-Zhen and Lu, Zheng-Zhou and Zhao, Ge-Xin and Sui, Sen-Fang and Zeng, Mu-Sheng and Liu, Zheng},
title = {Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202502231}
}
EUVIMED